Loading clinical trials...
Loading clinical trials...
Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest - a Randomized Clinical Trial
Conditions
Interventions
Tocilizumab 20 Mg/mL Intravenous Solution
isotonic saline
Locations
1
Denmark
Rigshospitalet
Copenhagen, Denmark
Start Date
March 4, 2019
Primary Completion Date
December 23, 2019
Completion Date
June 30, 2020
Last Updated
August 21, 2020
NCT07438938
NCT06939335
NCT06567912
NCT06776549
NCT06067204
NCT02309151
Lead Sponsor
Christian Hassager
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions